RFSA



|Being addressed |Solution exists but there are economic issues |Issues with |Existing solution |No solution in sight | |

| | |applying | |Expert input to be conducted | |

| | |cascade | | | |

|Injectable antibiotics as |Penicillin procaine and benzathine. |4 |5 |Veterinary drugs needed, preferably for use in horses, based on penicillin |MA for pheneticillin-based veterinary drugs |

|“first-line” treatment | | | |sodium and amoxicillin sodium. Veterinary drugs unavailable: STOP M |is under way. |

| | | | |(penicillin sodium) out of stock, CLAMOXYL (amoxicillin) dropped and | |

| | | | |PENETAVET (pheneticillin) withdrawn. | |

| | | | |Use of procaine is restricted due to risk of neurological reactions. The | |

| | | | |alternatives are Excenel or Cobactan. | |

|Rhodococcus |Cure: drugs for human use: azithromycin / tulathromycin | 3 |5 |Vaccine awaited (under development). Would avoid having to resort to critical|Data on volume of autologous vaccine to be |

| |+ Rifampicin. Veterinary erythromycin not always | | |antibiotics. |used pending collection. |

| |effective and can cause diarrhoea among foals. | | |Efficacy of autologous vaccines pending evaluation. | |

| | | | | | |

| |+ | | | | |

|Piroplasmosis | |3 |3 |CARBESIA: the 213-day bovine withdrawal period cannot be applied in practice.| |

|Leptospirosis |Cure: tetracyclines. |2 |2 |Vaccine requested. Would avoid antibiotic treatment. | |

|Immune mechanism stimulator|Parapox type immunomodulator (Zylexis ND). |2 |2 |Alternative to use of antibiotics. |Zylexis MA not submitted in the end (efficacy|

| | | | |Available with MA in Europe, combating fraudulent imports, among which via |not proven, etc.). |

| | | | |Internet. |“Limited market authorisation” in UK since |

| | | | | |2012. |

|Chondroprotective corticoid|Triamcinolone acetonide-based drug for human use. |1 |3 |Intra-articular injection triamcinolone is the only corticoid considered to |No information on withdrawal of CANITEDAROL. |

| | | | |be chondroprotective. Triamcinolone diacetate-based CANITEDAROL veterinary | |

| | | | |drug – dogs, cats – is no longer marketed. | |

|Myositis |Vit E for veterinary or human use: dantrolene |1 |2 |Vit E not particularly effective. A dantrolene-based veterinary drug would be| |

| |(DANTRIUM). | | |beneficial. | |

|Lactation induction |Human drug: sulpiride. |1 |2 |Veterinary drug needed. | |

|Botulism |Bovine serum. |1 |1 |No equine vaccine or serum available. |Possibility of importing ANTRAVAX bovine |

| | | | | |vaccine. |

|Antibiotic against |Drug for human use. |1 |1 |A metronidazole-based veterinary drug is required. |Only for use in horses not intended for human|

|anaerobes (pleuropneumonia)| | | | |consumption. |

|Fungal keratitis |Injection drugs for human use: natamycin or fungizone. |1 |1 |A veterinary drug suitable for ophthalmic application is required. | |

|Alpha-2 agonist antagonist |Drug for human use: yohimbine. |0 |1 |A veterinary drug would be very useful. | |

|(detomidine) | | | | | |

|Chemical castration |IMPROVAC. |0 |1 |Vaccination reactions with IMPROVAC. No significant demand at present, but | |

| | | | |likely to arise given general context of increased awareness of animal | |

| | | | |wellbeing. EQUITY exists in Australia and NZ. | |

|Allergies – Oral treatment |Dexamethasone in injection presentation. |2 |3 |Prednisolone or dexamethasone in oral administration presentation needed. |MA for EQUISOLON prednisolone-based oral |

| | | | | |powders for horses since 03/2014. |

|Anaesthetic |Drug for human use: diazepam. |0 |1 | |MA for DIAZEPAM TVM 5MG/ML since 02/2014. |

|Analgesic |Buprenorphine for cats and dogs. |0 |1 |A veterinary drug for horses would be very useful. The only opioid available |MA for BUPRENODALE MULTIDOSE, 0.3mg/ml |

| | | | |for use in horses is butorphanol, which has low analgesic effect and short |SOLUTION FOR INJECTION FOR DOGS, CATS and |

| | | | |duration of action. |HORSES since 08/2013. Marketing authorised as|

| | | | | |of 01/01/2015. |

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download